Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab + Sorafenib in Metastatic Breast Cancer
NCT00632541Phase 2Terminated
- Sponsor
- Hoosier Cancer Research Network
- Start
- Oct 2007
- Primary completion
- Mar 2009
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib, bevacizumab in breast cancer, sponsored by Hoosier Cancer Research Network. Started Oct 2007; status: terminated.
02
Drugs
sorafenibbevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00632541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00632541.